Authors:
Van Reeth, O
Weibel, L
Olivares, E
Maccari, S
Mocaer, E
Turek, FW
Citation: O. Van Reeth et al., Melatonin or a melatonin agonist corrects age-related changes in circadianresponse to environmental stimulus, AM J P-REG, 280(5), 2001, pp. R1582-R1591
Authors:
Challet, E
Dugovic, C
Turek, FW
Van Reeth, O
Citation: E. Challet et al., The selective neurokinin 1 receptor antagonist R116301 modulates photic responses of the hamster circadian system, NEUROPHARM, 40(3), 2001, pp. 408-415
Authors:
Challet, E
Turek, FW
Laute, MA
Van Reeth, O
Citation: E. Challet et al., Sleep deprivation decreases phase-shift responses of circadian rhythms to light in the mouse: role of serotonergic and metabolic signals, BRAIN RES, 909(1-2), 2001, pp. 81-91
Authors:
Weibel, L
Turek, FW
Mocaer, E
Van Reeth, O
Citation: L. Weibel et al., A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle, BRAIN RES, 880(1-2), 2000, pp. 207-211
Authors:
Van Reeth, O
Olivares, E
Zhang, Y
Tripathi, B
Turek, FW
Citation: O. Van Reeth et al., Chronobiotic effects of gepirone, a potential antidepressant with 5HT(1A) receptor partial agonist properties, BEHAV PHARM, 10(2), 1999, pp. 119-130
Citation: G. Copinschi et al., The aging process and desynchronization between endogenous rhythmicity andenvironmental conditions, PRESSE MED, 28(17), 1999, pp. 942-946
Authors:
Dugovic, C
Maccari, S
Weibel, L
Turek, FW
Van Reeth, O
Citation: C. Dugovic et al., High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations, J NEUROSC, 19(19), 1999, pp. 8656-8664
Authors:
Koehl, M
Darnaudery, M
Dulluc, J
Van Reeth, O
Le Moal, M
Maccari, S
Citation: M. Koehl et al., Prenatal stress alters circadian activity of hypothalamo-pituitary-adrenalaxis and hippocampal corticosteroid receptors in adult rats of both gender, J NEUROBIOL, 40(3), 1999, pp. 302-315
Authors:
Weibel, L
Rettori, MC
Lesieur, D
Delagrange, P
Renard, P
Van Reeth, O
Citation: L. Weibel et al., A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice, BRAIN RES, 829(1-2), 1999, pp. 160-166